Skip to main content
. 2024 Jul 12;36(2):128–136. doi: 10.37616/2212-5043.1386

Table 2.

Estimated 10 Year CV risk score according to presence or absence of CAD.

Risk score Non-obstructive CAD N = 400(%) Obstructive CAD N = 813(%) Total N = 1213 P-value
QRISK3 (N = 1208)
Mean score ±SD 12.8 ± 13.14 22.13 ± 14.25 19.08 ± 14.01 <0.0001
Patients with <20% 10-year risk, n (%) 304(77) 410(50.4) 714(59.1) <0.0001
Patients with ≥20% 10-year risk, n (%) 91(23) 403(49.6) 494(40.9) <0.0001
GRACE (N = 1208)
Mean score ±SD 109.12 ± 32.86 138.83 ± 25.23 129.11 ± 31.23 <0.0001
Patients with <20% 10-year risk, n (%) 333(83.3) 434(53.4) 767(63.2) <0.0001
Patients with ≥20% 10-year risk, n (%) 62(15.5) 379(46.6) 441(36.4) <0.0001
FRS CHD(N = 1213)
Mean score ±SD 7.55 ± 7.36 13.16 ± 8.22 11.31 ± 8.37 <0.0001
Patients with <20% 10-year risk, n (%) 349(87.3) 576(70.8) 925(76.3) <0.0001
Patients with ≥20% 10-year risk, n (%) 51(12.8) 237(29.2) 288(23.7) <0.0001
ASCVD(N = 1152)
Mean score ±SD 9.07 ± 9.42 16.17 ± 12.35 13.96 ± 11.97 <0.0001
Patients with <20% 10-year risk, n (%) 314(78.5) 547(67.3) 861(71) <0.0001
Patients with ≥20% 10-year risk, n (%) 46(11.5) 245(30.1) 291(24) <0.0001

QRISK3 score-QRESEARCH version 3; GRACE-Global Registry of Acute Coronary Events; FRS-CHD-Framingham risk score; ASCVD-Atherosclerotic cardiovascular disease risk score, SERENE-CAG-Selecting Patients Of Rheumatic Heart Disease Undergoing Valve Surgery For Presurgical Coronary Angiography.